NanoViricides ($NNVC) plans to explore additional indications for NV-387, including Influenza and COVID-19, through partnerships and non-dilutive funding. The drug’s broad-spectrum activity opens doors for treating various respiratory and viral infections.


Know more: http://tiny.cc/iulxzz